Efficacy News and Research

RSS

Researchers discover potential novel strategy for improving immunotherapy against cancer

Researchers at the University of North Carolina Lineberger Comprehensive Cancer Center have discovered a potential novel strategy for improving drugs that unleash the immune system against cancer -- by binding two compounds to a nanoparticle.

3 Apr 2017

UK Medical announce range expansion of biopsy products to interventional products

A Sheffield healthcare company has today announced a strategic ‘buy out’ from its parent company, BD (Becton, Dickinson and Company), a deal which will see the company independently trade once again as UK Medical Ltd.

3 Apr 2017

Amgen, UCB present romosozumab Phase 2 results at ENDO 2017

Amgen and UCB today announced results from the fourth year of a Phase 2 study showing the efficacy and safety of a second course of treatment with EVENITY™* (romosozumab), an investigational agent for postmenopausal women with osteoporosis.

3 Apr 2017

USAHS experts to present key occupational therapy research at AOTA Annual Conference

University of St. Augustine Health Sciences, a leading graduate institution that emphasizes health science education through innovative classroom education, is proud to announce that several faculty members will be presenting key research at the American Occupational Therapy Association Annual Conference & Centennial Celebration in Philadelphia, March 30 - April 2.

31 Mar 2017

Combination of TTFields with standard therapies may improve survival in pancreatic cancer patients

Novocure announced today results from the second cohort of its phase 2 pilot PANOVA trial studying Tumor Treating Fields (TTFields) in combination with nab-paclitaxel and gemcitabine for the treatment of advanced pancreatic cancer.

31 Mar 2017

Phase 2 study shows encouraging results for TTFields therapy in treating recurrent ovarian cancer

Novocure announced today results from its phase 2 pilot INNOVATE trial studying Tumor Treating Fields (TTFields) in combination with weekly paclitaxel for the treatment of recurrent ovarian cancer.

31 Mar 2017

PAREXEL introduces patient sensor solution for improved data collection in clinical trials

PAREXEL International Corporation, a leading global biopharmaceutical services provider, today announced the launch of its patient sensor solution, a new offering that securely captures, transmits, stores, and visualises study subject data in clinical trials.

From Parexel 31 Mar 2017

Researchers explore factors that influence patient's intent to get colorectal cancer screening

A patient's confidence in their ability to schedule, plan for and properly conduct their part in colorectal screening methods is a key factor that predicts whether they intend to be tested, according to new research from Penn State College of Medicine. The findings suggest that educating patients could improve screening rates.

30 Mar 2017

UAB chemists design microcapsules for guided drug delivery system to target solid tumors

Chemists at the University of Alabama at Birmingham have designed triple-threat cancer-fighting polymer capsules that bring the promise of guided drug delivery closer to preclinical testing.

30 Mar 2017

FDA approves new therapy for adult patients with relapsing and primary progressive MS

On March 28, the U.S. Food and Drug Administration approved Ocrevus (ocrelizumab) to treat adult patients with relapsing forms of multiple sclerosis (MS) and primary progressive multiple sclerosis (PPMS).

29 Mar 2017

City of Hope researchers to highlight basic cancer research and population studies at AACR meeting

City of Hope, a world-renowned independent research and cancer and diabetes treatment center, will highlight a variety of basic research and population studies at the annual meeting of the American Association for Cancer Research at the Walter E. Washington Convention Center in Washington, D.C., April 1 to 5.

28 Mar 2017

Public-private collaboration to develop more accurate methods of tracking cancer progression

Columbia University Medical Center and NewYork-Presbyterian, in coordination with the Foundation for the National Institutes of Health Biomarkers Consortium, is launching a three-year research collaboration to develop new methods for analyzing digital images that track a patient's response to cancer therapy.

28 Mar 2017

FDA approves new maintenance therapy for recurrent cancers

The U.S. Food and Drug Administration today approved Zejula (niraparib) for the maintenance treatment (intended to delay cancer growth) of adult patients with recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer, whose tumors have completely or partially shrunk (complete or partial response, respectively) in response to platinum-based chemotherapy.

27 Mar 2017

Researchers discover how fat soluble vitamins may offer viable solution for treating cystic fibrosis

Researchers from Queen's University Belfast have discovered why antibiotics for treating people with cystic fibrosis are becoming less effective and how fat soluble vitamins might offer a viable solution.

27 Mar 2017

SNIFF study to examine safety, efficacy of nasal insulin for treating Alzheimer’s disease

Can insulin, the hormone used for nearly a century to treat diabetes, improve cognition, memory and daily function in people with mild cognitive impairment or mild dementia due to Alzheimer's disease? Rush University Medical Center is testing this innovative potential treatment as part of a new nationwide study.

25 Mar 2017

Virtual environment education decreases anxiety before prostate cancer treatment

Radiation therapists and physicians know that education can reduce anxiety before radiation treatment but lack a standardized tool. In an effort to solve this problem, a multidisciplinary team from Jefferson College of Health Professions and Sidney Kimmel Cancer Center at Thomas Jefferson University conducted a pilot study to see if a virtual environment education program could reduce some of the anxiety their patients face.

25 Mar 2017

Report: Global increase in drug-resistant TB threatens to ruin efforts to eradicate the disease

The rise of multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis (TB) threatens to derail decades of progress in controlling the disease, according to a new report in The Lancet Respiratory Medicine published on World TB day (24th March).

25 Mar 2017

UNC scientists receive NIH grant to develop new implantable drug delivery system for HIV prevention

Researchers at the University of North Carolina at Chapel Hill have received a three-year, $1.8 million grant from the National Institutes of Health to develop a new implantable drug delivery system for long-lasting HIV-prevention.

25 Mar 2017

MSK scientists discover epigenetic mechanism promoting breast cancer

Researchers from Memorial Sloan Kettering Cancer Center (MSK) have identified, for the first time, an epigenetic mechanism promoting breast cancer.

24 Mar 2017

New clinical approach offers hope for patients with aggressive brain cancer

Being diagnosed with a malignant brain tumor is devastating news for patients and their loved ones. Whereas some types of tumor respond well to treatment, others such as glioblastomas - the most common and aggressive brain tumors - are known to recur and progress within short times from the diagnosis.

23 Mar 2017

Efficacy News and Research

Researchers discover potential novel strategy for improving immunotherapy against cancer

UK Medical announce range expansion of biopsy products to interventional products

Amgen, UCB present romosozumab Phase 2 results at ENDO 2017

USAHS experts to present key occupational therapy research at AOTA Annual Conference

Combination of TTFields with standard therapies may improve survival in pancreatic cancer patients

Phase 2 study shows encouraging results for TTFields therapy in treating recurrent ovarian cancer

PAREXEL introduces patient sensor solution for improved data collection in clinical trials

Researchers explore factors that influence patient's intent to get colorectal cancer screening

UAB chemists design microcapsules for guided drug delivery system to target solid tumors

FDA approves new therapy for adult patients with relapsing and primary progressive MS

City of Hope researchers to highlight basic cancer research and population studies at AACR meeting

Public-private collaboration to develop more accurate methods of tracking cancer progression

FDA approves new maintenance therapy for recurrent cancers

Researchers discover how fat soluble vitamins may offer viable solution for treating cystic fibrosis

SNIFF study to examine safety, efficacy of nasal insulin for treating Alzheimer’s disease

Virtual environment education decreases anxiety before prostate cancer treatment

Report: Global increase in drug-resistant TB threatens to ruin efforts to eradicate the disease

UNC scientists receive NIH grant to develop new implantable drug delivery system for HIV prevention

MSK scientists discover epigenetic mechanism promoting breast cancer

New clinical approach offers hope for patients with aggressive brain cancer

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News